从印度印度北方邦的公共卫生药物供应链模型重新设计中吸取的经验教训
Vasanthakumar Namasivayam1, Manuj Purwar2,3, Sushant Jain2,3
1Government of India, Union Territory of Ladakh, Leh, India.
Frontiers in public health
|August 11, 2025
概括
在印度北方邦实施重新设计的药品供应链,大大提高了必需药品的可用性,从40%提高到近100%. 这一公共卫生倡议为面临类似供应链挑战的其他地区提供了一个可扩展的模型.
科学领域:
- 公共卫生 公共卫生
- 供应链管理 供应链管理
- 加强卫生系统 加强卫生系统
背景情况:
- 印度人口最多的北方邦 (Uttar Pradesh) 面临着在3万多个公共卫生设施中确保持续获得必需药物的重大挑战.
- 2017年的一次审计显示,药品供应存在大量缺口,强调需要强有力的供应链重新设计.
研究的目的:
- 描述从泰米尔纳德邦的医疗用品公司 (TNMSC) 吸取经验教训,为北方邦的医疗用品公司 (UPMSC) 重新设计药品供应链模型.
- 确定成功的公共卫生供应链的关键支柱和流程,并评估它们对药物可用性和运营效率的影响.
主要方法:
- 通过桌面审查和TNMSC的学习,确定了公共卫生供应链的七大基本支柱.
- 实施了关键流程,以加强供应商参与,减少依赖,同步招标,并建立药品取货名单.
- 在UPMSC和设施负责人之间定义了一个明确的责任矩阵.
主要成果:
- 基本药品的可用性从大约40%提高到近100%,平均每仓库可用287种药物中有275种.
- 供应订单从5800万美元增加到1.12亿美元,到2024年4月,设施消费价值从3800万美元增加到9000万美元.
- 经过重新设计的系统显示了更高的运营效率和更好的药物可访问性.
结论:
- 系统设计对于有效的公共卫生供应链至关重要,UPMSC的成功证明了这一点.
- 七支柱模式和实施的流程为印度其他州和低收入和中低收入国家 (LMICs) 提供了有价值的见解.
- 虽然取得了显著的改进,但最后一英里交付和供应商支付方面的挑战仍然存在,需要持续关注.
相关概念视频
Methods Of Healthcare Delivery System
3.5K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.5K
Primary Healthcare Services
1.5K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.5K
Three-Compartment Open Model
428
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
428
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Model Approaches for Pharmacokinetic Data: Physiological Models
110
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
110
Analysis of Population Pharmacokinetic Data
383
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
383


